文献速递腹部介入技术与安全US

利用人工智能在超声造影中准确预测肝细胞癌患者对经动脉化疗栓塞的反应

Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
PubMed 文献 · Eur Radiol · 2020-01-03

本研究回顾性纳入130例肝细胞癌患者,基于首次TACE术前1周内的超声造影电影和B模式图像构建深度学习影像组学模型,预测TACE客观缓解。验证队列中R-DLCEUS的AUC为0.93,显著高于R-TIC(0.80)和R-BMode(0.81),后两者无显著差异;模型可重复性好且操作简便。

要点

  • 基于术前超声造影电影的深度学习影像组学模型可预测肝细胞癌首次TACE的客观缓解,验证队列AUC为0.93。
  • R-DLCEUS的AUC显著高于R-TIC(0.80,p=0.034)和R-BMode(0.81,p=0.039),后两者间无显著差异。
  • 3D CNN分析可视化可直观显示计算机在超声造影电影上关注的区域,有助于理解模型判读。

关键影像表现/征象

  • 基于深度学习影像组学构建超声造影模型(R-DLCEUS),基于机器学习影像组学构建超声造影时间-强度曲线模型(R-TIC)和B模式图像模型(R-BMode)。
  • 以改良实体瘤疗效评价标准为参考,将TACE反应分为客观缓解和无缓解。
  • 采用受试者工作特征曲线下面积(AUC)比较模型性能,DeLong检验比较不同AUC,并评估各模型预测稳健性。

诊断标准与关键数值

  • 验证队列中R-DLCEUS的AUC为0.93(95% CI,0.80-0.98)。
  • 验证队列中R-TIC的AUC为0.80(95% CI,0.64-0.90)。
  • 验证队列中R-BMode的AUC为0.81(95% CI,0.67-0.95)。
  • R-DLCEUS的AUC与R-TIC相比差异有统计学意义(p=0.034),与R-BMode相比差异有统计学意义(p=0.039)。
  • R-TIC与R-BMode的AUC差异无统计学意义。

临床应用与阅片要点

  • 该深度学习影像组学方法可定量分析术前超声造影电影,预测肝细胞癌患者对首次TACE的客观缓解。
  • 超声造影模型采用的3D CNN分析可视化可直观显示计算机在超声造影电影上关注的区域,有助于理解超声造影数据的判读。
  • 所提出的预测方法操作简便且省力,能以极少的时间成本辅助肝细胞癌的临床治疗决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to establish and validate an artificial intelligence-based radiomics strategy for predicting personalized responses of hepatocellular carcinoma (HCC) to first transarterial chemoembolization (TACE) session by quantitatively analyzing contrast-enhanced ultrasound (CEUS) cines.

METHODS: One hundred and thirty HCC patients (89 for training, 41 for validation), who received ultrasound examination (CEUS and B-mode) within 1 week before the first TACE session, were retrospectively enrolled. Ultrasonographic data was used for building and validating deep learning radiomics-based CEUS model (R-DLCEUS), machine learning radiomics-based time-intensity curve of CEUS model (R-TIC), and machine learning radiomics-based B-Mode images model (R-BMode), respectively, to predict responses (objective-response and non-response) to TACE with reference to modified response evaluation criteria in solid tumor. The performance of models was compared by areas under the receiver operating characteristic curve (AUC) and the DeLong test was used to compare different AUCs. The prediction robustness was assessed for each model.

RESULTS: AUCs of R-DLCEUS, R-TIC, and R-BMode were 0.93 (95% CI, 0.80-0.98), 0.80 (95% CI, 0.64-0.90), and 0.81 (95% CI, 0.67-0.95) in the validation cohort, respectively. AUC of R-DLCEUS shows significant difference compared with that of R-TIC (p = 0.034) and R-BMode (p = 0.039), whereas R-TIC was not significantly different from R-BMode. The performance was highly reproducible with different training and validation cohorts.

CONCLUSIONS: DL-based radiomics method can effectively utilize CEUS cines to achieve accurate and personalized prediction. It is easy to operate and holds good potential for benefiting TACE candidates in clinical practice.

KEY POINTS: • Deep learning (DL) radiomics-based CEUS model can accurately predict responses of HCC patients to their first TACE session by quantitatively analyzing their pre-operative CEUS cines. • The visualization of the 3D CNN analysis adopted in CEUS model provided direct insight into what computers "see" on CEUS cines, which can help people understand the interpretation of CEUS data. • The proposed prediction method is easy to operate and labor-saving for clinical practice, facilitating the clinical treatment decision of HCCs with very few time costs.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Liu D, Liu F, Xie X, et al. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound. Eur Radiol. 2020. PMID: 31900703. doi:10.1007/s00330-019-06553-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。